PräklinischeErprobungvonPipeline‐
Substanzen in vitro Modellen
Tumor therapy
in vivo
Tumor model
in vivo
Primary human
tissue culture
tion
Patient
eratio
Analysis (Proliferation, Differentiation, Vascularisation)
onserv
O
Primary human
Tumor therapy
Tumor model
Cryo
ce
cu
ure
n v
tro
n
v
ro
Individuelles Thera
iekonze
t für Patienten mit endokrinen Tumoren
www.m4.de
Achievements
•Structuraloutcomes(12/2013):
• CentralizedITstructure:Upgradeanddatatransfertoanew andmorepowerful
databank
•
n
orme
consen
rom
en
er
ngo
c
n
ca
a
as
ongo
ng
•Bio‐sampling
:collectioninprogress: 401EDTA,300Plasma,350tumors (12/13)
•
: primary cell cultures, xenograft models
Investigationaloutcomes(12/2013):
• DualPI3K/mTORinhibitorsarepotentantiproliferativeagentsingastroenteropancreatic
neuroendocrinetumorsandnonfunctioningpituitaryadenomasinvitro
• Clinicalstudyprotocolforthecombinedsomatostatinanalog‐mTORinhibitorforthe
treatmentofaggressivepituitaryadenomasandotherneuroendocrinetumorsfinished
•Developmentofdiagnosticmicroarraysforneuroendocrinetumorsinprogress
•Firstepidemiologicalstudiesonthemetabolicandneuropsychiatric comorbiditiesfinished
www.m4.de
Achievements&Sustainabilit
MedIV+MPI:
•Prospectivefollow‐up examofpatientswithCushing`sdiseasefollowinga
standardized clinical protocol (Interview physical exam MRI biosampling
,
,
,
,
questionnairesetc.):178patientsincluded(02/14)
Eit fth t i G i (D d Bli Dü ld f
•
xpans
on
o
ur
ercen
res
n
ermany
nprogress
res
en,
er
n,
sse
or
,
Tübingen)
•Nextstep:Adaptionoftheprotocoltofurtherentitiesofpituitaryadenomas
(Acromegaly,NFPA,Prolactinoma).
•FurtherFunding:
•
Informal request at NAMSE (
Nationalen Aktionsbündnisses für Menschen mit
SeltenenErkrankungen)andElse‐Kröner‐Fresenius‐Stiftungforfollow‐up financing
www.m4.de
Vielen Dank für Ihre Aufmerksamkeit !
www.m4.de
Comments to this Manuals